resveratrol has been researched along with Pneumonia, Viral in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marinella, MA | 1 |
| Di Pietro, M; Filardo, S; Mastromarino, P; Sessa, R | 1 |
| Han, YJ; Ji, XY; Li, XX; Ma, CY; Ren, ZG; Wu, DD; Yan, JL | 1 |
| Jamshidi, M; Ranjbar, A; Torabi, S | 1 |
| Bachari, K; Ramdani, LH | 1 |
| Grebenchikov, OA; Zinovkin, RA | 1 |
2 review(s) available for resveratrol and Pneumonia, Viral
| Article | Year |
|---|---|
Therapeutic potential of resveratrol against emerging respiratory viral infections.
Topics: Antiviral Agents; Betacoronavirus; Communicable Diseases, Emerging; Coronavirus Infections; COVID-19; Humans; Influenza, Human; Pandemics; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Resveratrol; SARS-CoV-2; Virus Diseases | 2020 |
Advances and challenges in the prevention and treatment of COVID-19.
Topics: Amides; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Chloroquine; Chlorpromazine; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclophilins; Drug Development; Drug Repositioning; Drugs, Chinese Herbal; Endocytosis; Humans; Immune Sera; Interferon Inducers; Nucleic Acid Synthesis Inhibitors; Pandemics; Pneumonia, Viral; Pyrazines; Resveratrol; SARS-CoV-2; Viral Vaccines | 2020 |
4 other study(ies) available for resveratrol and Pneumonia, Viral
| Article | Year |
|---|---|
Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.
Topics: Animals; Antioxidants; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclooxygenase Inhibitors; Cytokines; Dogs; Humans; Indomethacin; Pandemics; Pneumonia, Viral; Resveratrol; SARS-CoV-2; Virus Replication | 2020 |
Molecular modelling of the antiviral action of Resveratrol derivatives against the activity of two novel SARS CoV-2 and 2019-nCoV receptors.
Topics: Antiviral Agents; Betacoronavirus; Binding Sites; Coronavirus Infections; Coronavirus Papain-Like Proteases; COVID-19; Crystallography, X-Ray; Hydrogen Bonding; Molecular Docking Simulation; Pandemics; Papain; Pneumonia, Viral; Protein Structure, Tertiary; Resveratrol; RNA-Dependent RNA Polymerase; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Viral Nonstructural Proteins | 2020 |
Potential therapeutic effects of Resveratrol against SARS-CoV-2.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Pneumonia, Viral; Resveratrol; SARS-CoV-2 | 2020 |
Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
Topics: Animals; Antioxidants; Betacoronavirus; Catechin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokines; Dimethyl Fumarate; Female; Humans; Immunosuppressive Agents; Inflammation; Isothiocyanates; Male; Mice; Molecular Targeted Therapy; NF-E2-Related Factor 2; Oxidative Stress; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Resveratrol; SARS-CoV-2; Signal Transduction; Sulfoxides; Thiosulfates | 2020 |